Novo Nordisk to Stop Insulin Sales in Greece
Novo Nordisk has decided to stop sales of its insulin product in Greece following a government decree ordering a 25% price cut in all medicines, according to a BBC report. The company, which claims it is owed 32 million dollars by the Greek state, said that such a price cut would force its business in Greece to run at a loss. The company was also concerned that the compulsory 25% reduction would have a knock-on effect since other countries use Greece as a key reference point for setting drug prices.
More than 50,000 Greeks with diabetes use Novo Nordisk’s insulin pen products.
Cross-posted on ASweetLife.
Follow us on twitter@thefastertimes
- 1 Brooklyn Man Now Living Entirely Off Own Beard Garden
- 2 “Cra Cra” Now Official Diagnosis in New DSM (DSM-5)
- 3 OfficeMax Marketing Director Struggling to Make Staplers ‘Sexy’ and ‘Conversational’
- 4 First Openly Straight Figure Skater Comes Forward
- 5 Area Man Tailors Life To Be More Relevant To His Hulu Advertisements
- 6 Fan Banging Furiously on Glass Could Be the Difference in Hockey Playoffs
- 7 Survey: 88% of Eagles Fans Too Drunk To Spell Nnamdi Asomugha Last Season
- 8 Attorney Actually Starting to Believe Own Bullshit
- 9 Homeless Guy Woos Silicon Valley VCs with Low-Tech Crowdfunding Strartup
- 10 Local Mom Won’t Stop Being First Person to Like Every Goddamn Thing Son Posts to Facebook